Futura Medical PLC (FUM)

Industry Biotechnology


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

1.215p

Buy

1.30p

arrow-down-0.062p (-4.77%)

Prices updated at 18 Dec 2025, 09:43 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Futura Medical PLC is a UK based drug manufacturer. Its business is to manufacture pharmaceutical products mainly for the treatment of erectile dysfunction and a measure against pain relief.
Sector
Healthcare
Industry
Biotechnology
Chairman
-
CEO
Mr. Alexander James Hanbury Duggan
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
17
Head office
40 Occam Road
Guildford
United Kingdom
GU2 7YG
mobile
+44 1483685670
letter
investor.relations@futuramedical.com

Key personnel

Salary
Mr. Andrew Vaughan Unitt
Non-Executive Director, Senior Independent Director
-
Mr. Gordon Roy Davis
Non-Executive Director
-
Mr. Kenneth William James
Executive Director, Head of RandD
-
Ms. Angela Hildreth
Executive Director, Finance Director, Chief Operating Officer and Company Secretary
-
Mr. Alexander James Hanbury Duggan
Executive Director, Chief Executive Officer (Interim)
-

Top 5 shareholders

No. of shares
Unicorn Asset Management Ltd5,750,000
Unicorn AIM VCT Series 3 ORD5,750,000
March Asset Management SGIIC410
Chelverton Asset Management Ltd-
MI Chelverton UK Equity Growth Fund-

Director dealings

Action
04 Dec 2025Purchase
04 Dec 2025Purchase
04 Dec 2025Purchase
13 Nov 2025Sale
16 Jan 2025Purchase
16 Jan 2025Purchase
16 Jan 2025Purchase
16 Jan 2025Purchase
16 Jan 2025Purchase
16 Jan 2025Purchase
16 Jan 2025Purchase
16 Jan 2025Purchase
16 Jan 2025Purchase
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.